Comparison of inflammation-based prognostic scores as predictors of survival outcomes in patients with germ cell tumors.
Kasumi YoshinagaTakuya SadahiraYuki MaruyamaYosuke MitsuiTakehiro IwataKoichiro WadaMotoo ArakiToyohiko WatanabeYasutomo NasuPublished in: Investigative and clinical urology (2020)
We demonstrated that the GPS was the most valuable biomarker of OS and PFS in patients with GCTs.
Keyphrases